Literature DB >> 17363621

Hepatic steatosis and plasma dyslipidemia induced by a high-sucrose diet are corrected by an acute leptin infusion.

Wan Huang1, Nikolas Dedousis, Robert M O'Doherty.   

Abstract

High sucrose (HS) feeding in rats induces hepatic steatosis and plasma dyslipidemia. In previous reports (Huang W, Dedousis N, Bhatt BA, O'Doherty RM. J Biol Chem 279: 21695-21700, 2004; and Huang W, Dedousis N, Bandi A, Lopaschuk GD, O'Doherty RM. Endocrinology 147: 1480-1487, 2006), our laboratory demonstrated a rapid ( approximately 100 min) leptin-induced decrease in liver and plasma VLDL triglycerides (TG) in lean rats, effects that were abolished in obese rats fed a high-fat diet, a model that also presents with hepatic steatosis and plasma dyslipidemia. To further examine the capacity of acute leptin treatment to improve metabolic abnormalities induced by nutrient excess, hepatic leptin action was studied in rats after 5 wk of HS feeding. HS feeding induced hepatic steatosis (TG+80+/-8%; P=0.001), plasma hyperlipidemia (VLDL-TG+102+/-14%; P=0.001), hyperinsulinemia (plasma insulin +67+/-12%; P=0.04), and insulin resistance as measured by homeostasis model assessment (+125+/-20%; P=0.02), without increases in adiposity or plasma leptin concentration compared with standard chow-fed controls. A 120-min infusion of leptin (plasma leptin 13.6+/-0.7 ng/ml) corrected hepatic steatosis (liver TG-29+/-3%; P=0.003) and plasma hyperlipidemia in HS (VLDL-TG-42+/-4%; P=0.001) and increased plasma ketones (+45+/-3%; P=0.006), without altering plasma glucose, insulin, or homeostasis model assessment compared with saline-infused HS controls. In addition, leptin activated liver phosphatidylinositol 3-kinase (+70+/-18%; P=0.01) and protein kinase B (Akt; +90+/-29%; P=0.02), and inhibited acetyl-CoA carboxylase (40+/-7%; P=0.04) in HS, further demonstrating that hepatic leptin action was intact in these animals. We conclude that 1) leptin action on hepatic lipid metabolism remains intact in HS-fed rats, 2) leptin rapidly reverses hepatic steatosis and plasma dyslipidemia induced by sucrose, and 3) the preservation of hepatic leptin action after a HS diet is associated with the maintenance of low adiposity and plasma leptin concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363621     DOI: 10.1152/japplphysiol.01449.2006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  14 in total

Review 1.  Counterregulation of insulin by leptin as key component of autonomic regulation of body weight.

Authors:  Katarina T Borer
Journal:  World J Diabetes       Date:  2014-10-15

2.  Decrease in hepatic very-low-density lipoprotein-triglyceride secretion after weight loss is inversely associated with changes in circulating leptin.

Authors:  F Magkos; E Fabbrini; J McCrea; B W Patterson; J C Eagon; S Klein
Journal:  Diabetes Obes Metab       Date:  2010-07       Impact factor: 6.577

3.  Leptin augments the acute suppressive effects of insulin on hepatic very low-density lipoprotein production in rats.

Authors:  Wan Huang; Anantha Metlakunta; Nikolas Dedousis; Heidi K Ortmeyer; Maja Stefanovic-Racic; Robert M O'Doherty
Journal:  Endocrinology       Date:  2009-01-15       Impact factor: 4.736

4.  Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.

Authors:  Meenakshi Sundaram; Zemin Yao
Journal:  Nutr Metab (Lond)       Date:  2010-04-27       Impact factor: 4.169

5.  Hepatic gene expression profiling reveals key pathways involved in leptin-mediated weight loss in ob/ob mice.

Authors:  Ashok Sharma; Shoshana M Bartell; Clifton A Baile; Bo Chen; Robert H Podolsky; Richard A McIndoe; Jin-Xiong She
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

6.  Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice.

Authors:  Victoria J Vieira; Rudy J Valentine; Kenneth R Wilund; Nirav Antao; Tracy Baynard; Jeffrey A Woods
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-03-10       Impact factor: 4.310

7.  Liver TAG transiently decreases while PL n-3 and n-6 fatty acids are persistently elevated in insulin resistant mice.

Authors:  Ludger Scheja; Klaus Toedter; Raoul Mohr; Gerhard Niederfellner; Mervyn D Michael; Axel Meissner; Anja Schoettler; Heike Pospisil; Ulrike Beisiegel; Joerg Heeren
Journal:  Lipids       Date:  2008-09-02       Impact factor: 1.880

8.  Body weight reduction in rats by oral treatment with zinc plus cyclo-(His-Pro).

Authors:  M K Song; M J Rosenthal; A M Song; K Uyemura; H Yang; M E Ament; D T Yamaguchi; E M Cornford
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

9.  Effects of Nonpurified and Choline Supplemented or Nonsupplemented Purified Diets on Hepatic Steatosis and Methionine Metabolism in C3H Mice.

Authors:  Raisa Syed; Noreene M Shibata; Kusum K Kharbanda; Ruijun J Su; Kristin Olson; Amy Yokoyama; John C Rutledge; Kenneth J Chmiel; Kyoungmi Kim; Charles H Halsted; Valentina Medici
Journal:  Metab Syndr Relat Disord       Date:  2016-02-16       Impact factor: 1.894

10.  Glucagon-Receptor Signaling Reverses Hepatic Steatosis Independent of Leptin Receptor Expression.

Authors:  Shelly R Nason; Teayoun Kim; Jessica P Antipenko; Brian Finan; Richard DiMarchi; Chad S Hunter; Kirk M Habegger
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.